← Back to Search

Pain self-management program for Chronic Pain

N/A
Waitlist Available
Led By Anne Marie Pinard, MD, M(Ed.)
Research Sponsored by CHU de Quebec-Universite Laval
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (8 weeks); 3 months post-intervention
Awards & highlights

Study Summary

This trial is designed to assess the feasibility and acceptability of an online self-management program for chronic non-cancer pain, as well as its potential effects on various aspects of pain and mental health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (8 weeks); 3 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (8 weeks); 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Adherence to the program
Feasibility of data collection
+1 more
Secondary outcome measures
Change in anxiety and depression: French version of the Hospital Anxiety and Depression Scale (HADS)
Change in pain catastrophizing: French version of the Pain Catastrophizing Scale (PCS)
Change in pain severity and pain interference: French version of the Brief Pain Inventory (BPI)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pain self-management programExperimental Treatment1 Intervention
Participants log in to the online program and develop practical strategies to manage CNCP.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pain self-management program
2022
N/A
~310

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalLead Sponsor
167 Previous Clinical Trials
107,094 Total Patients Enrolled
1 Trials studying Chronic Pain
38 Patients Enrolled for Chronic Pain
Anne Marie Pinard, MD, M(Ed.)Principal InvestigatorCHU de Quebec-Universite Laval

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment amount for this research endeavor?

"Indeed, the clinical trial registry suggests that recruitment is still ongoing for this investigation. It first went live on June 6th of 2022 and has been modified since then. The study hopes to enlist 100 test subjects at a single site."

Answered by AI

What aims does this research endeavor have?

"This medical trial will be evaluated over a 3 month period post-intervention to determine its efficacy in terms of patient adherence. Secondary outcomes encompass three distinct assessments: the French version of the Pain Catastrophizing Scale (PCS) for gauging rumination, magnification and helplessness with regards to pain; the Brief Pain Inventory's (BPI) scale which measures both severity and interference from pain; as well as a Patient Global Impression of Change Scale (PGIC), rating overall improvement or lack thereof due to intervention on a 7 point scale."

Answered by AI

Is the recruitment of participants still taking place for this clinical trial?

"As seen on clinicaltrials.gov, the study is presently enrolling participants. It was first publicized on June 6th 2022 and last modified a fortnight later, on June 21st of the same year."

Answered by AI

Who else is applying?

What state do they live in?
Quebec
What site did they apply to?
CHU de Québec
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I was diagnosed with Fibromyalgia a year ago after 6 years of tests and wrong diagnoses and was started on pregabalin currently with little success. I’m in a lot of pain and I’m desperate for new solutions.
PatientReceived no prior treatments
~22 spots leftby Apr 2025